| Primary |
| Angina Pectoris |
30.0% |
| Chronic Obstructive Pulmonary Disease |
20.0% |
| Coronary Artery Disease |
20.0% |
| Anxiety |
10.0% |
| Cardiac Failure |
10.0% |
| Polymyalgia Rheumatica |
10.0% |
|
| Mesothelioma |
28.6% |
| Multiple Myeloma |
14.3% |
| Photophobia |
14.3% |
| Photosensitivity Reaction |
14.3% |
| Rash |
14.3% |
| Renal Failure Chronic |
14.3% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
23.5% |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
21.2% |
| Hypertension |
7.1% |
| Constipation |
4.7% |
| Fluid Retention |
3.5% |
| Angina Pectoris |
2.4% |
| Antiplatelet Therapy |
2.4% |
| Coronary Artery Disease |
2.4% |
| Epilepsy |
2.4% |
| Plasma Cell Myeloma |
2.4% |
| Anxiety |
1.2% |
| Asthma |
1.2% |
| Chronic Myeloid Leukaemia |
1.2% |
| Polymyalgia Rheumatica |
1.2% |
|
| Mesothelioma |
41.7% |
| Fall |
8.3% |
| Hyponatraemia |
8.3% |
| Renal Failure Acute |
8.3% |
| White Blood Cell Count Decreased |
8.3% |
| Bone Marrow Failure |
4.2% |
| Gout |
4.2% |
| Lung Neoplasm Malignant |
4.2% |
| Malaise |
4.2% |
| Photophobia |
4.2% |
| Renal Failure Chronic |
4.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
48.1% |
| Atrial Fibrillation |
8.1% |
| Hypertension |
8.1% |
| Product Used For Unknown Indication |
7.5% |
| Rheumatoid Arthritis |
6.0% |
| Myocardial Ischaemia |
4.0% |
| Osteoporosis |
3.3% |
| Depression |
1.5% |
| Pain |
1.5% |
| Relapsing-remitting Multiple Sclerosis |
1.5% |
| Wound Infection |
1.5% |
| Gastric Disorder |
1.2% |
| Psoriatic Arthropathy |
1.2% |
| Angina Pectoris |
1.0% |
| Hypokalaemia |
1.0% |
| Pulmonary Arterial Hypertension |
1.0% |
| Smoking Cessation Therapy |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
| Cardiovascular Event Prophylaxis |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
|
| Progressive Multifocal Leukoencephalopathy |
13.3% |
| Tremor |
8.4% |
| Myocardial Infarction |
7.2% |
| Renal Failure |
7.2% |
| Death |
6.0% |
| Syncope |
6.0% |
| International Normalised Ratio Increased |
4.8% |
| Osteonecrosis |
4.8% |
| Pulmonary Embolism |
4.8% |
| Staphylococcal Infection |
4.8% |
| Angina Pectoris |
3.6% |
| Liver Function Test Abnormal |
3.6% |
| Pharmaceutical Product Complaint |
3.6% |
| Pleural Effusion |
3.6% |
| Shock |
3.6% |
| Unevaluable Event |
3.6% |
| Urinary Retention |
3.6% |
| Completed Suicide |
2.4% |
| Lethargy |
2.4% |
| Melaena |
2.4% |
|
